Patent pools for generic drugs

Mark Schankerman interviewed by Tim Phillips, 19 February 2021

a

A

Topics:  Competition policy Covid-19 Health economics

Tags:  procurement, medicine, COVID-19

Professor of Economics, London School of Economics and CEPR Research Fellow

CEPR Policy Research